Serum Institute Wins USFDA Nod To Export Novavax COVID Jab
The FDA has given the go-ahead to the Serum Institute of India (SII) to eventually supply a COVID-19 vaccine to the U.S. with Novavax's...
FDA Clears Novavax COVID-19 Vaccine As Fourth Option In US
As infections in the U.S. continue to be at high levels, the Food and Drug Administration on 13th July approved a fourth vaccination for...
Paxlovid Allowed By FDA To Sell At Certified Pharmacies
On July 6, the US Food and Drug Administration modified the COVID-19 antiviral drug Paxlovid's emergency use authorization to permit state-licensed pharmacists to recommend the...
FDA Advises Adding Omicron BA.4, 5 To COVID-19 Boosters
The Vaccines and Related Biological Products Advisory Panel of the U.S. Food and Drug Administration gathered on June 30th to evaluate whether a change to...
FDA Experts Recommend Changing COVID Jab Formulation In Fall
To address more recently circulating coronavirus strains, advisors to the U.S. Food and Drug Administration recently suggested altering the design of COVID-19 booster doses this...
FDA Officials Support Moderna, Pfizer COVID-19 Jabs For Kids
Parents may soon be allowed to line up their children for vaccinations after Pfizer and Moderna's COVID-19 vaccine application for young children progresses through...
FDA Not So Fast On Approval Of The Novavax COVID-19 Vaccine
The US handed Novavax a $1.6 billion funding 4 months into the pandemic, in July 2020, to speed the biotech's research of a coronavirus...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...